Le Lézard
Classified in: Health, Science and technology

Global Marine Biotechnology Market Expected to Grow with a CAGR of 8% During the Forecast Period, 2020-2024 - ResearchAndMarkets.com


The "Global Marine Biotechnology Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Global Marine Biotechnology Market 2020-2024

The analyst has been monitoring the global marine biotechnology market and it is poised to grow by USD 2.5 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period.

This report on the global marine biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in demand for biofuel. In addition, increasing application of seaweeds is anticipated to boost the growth of the global marine biotechnology market as well.

Key Trends for global marine biotechnology market growth

This study identifies increasing application of seaweeds as the prime reasons driving the global marine biotechnology market growth during the next few years.

Key Topics Covered:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by Application

Customer landscape

Geographic Landscape

Drivers, Challenges, and Trends

Vendor Landscape

Vendor Analysis

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/4va2oa


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: